Longeveron (LGVN) Announces Board Changes

Go back to Longeveron (LGVN) Announces Board Changes

Longeveron Announces Board of Directors Planned Transitions

May 10, 2024 4:05 PM EDT

Richard Kender, retired SVP of Business Development and Corporate Licensing for Merck & Co., Inc., has been appointed to the Longeveron BoardDr. Roger Hajjar, former head of R&D at Ring Therapeutics, has been nominated as a candidate for the Board, subject to election at the Companys Annual Meeting of StockholdersNeha Motwani, former managing director and senior healthcare investment banker at William Blair, Truist, and Oppenheimer and Company, also has been nominated as a candidate for the Board, subject to election at the Companys... More